Home Newsfeeds Exane BNP Paribas Downgrades Chevron to Underperform

Exane BNP Paribas Downgrades Chevron to Underperform

Exane BNP Paribas analyst Lucas Herrmann downgrades Chevron (NYSE:CVX) from Neutral to Underperform.

byBenzinga Newsdesk

December 14, 2022

1 minute read

Exane BNP Paribas analyst Lucas Herrmann downgrades Chevron (NYSE:CVX) from Neutral to Underperform.

Cross-Border E-commerce Trader Zibuyu Files for IPO Despite Sinking Profits

By The Bamboo Works

October 7, 10:35 AM

Key Takeaways: Cross-border e-commerce company Zibuyu has filed for a Hong Kong IPO, but could be undermined by its heavy reliance on Amazon and the U.S. market The company’s first-half profit plunged 46% as its merchandise return rates and costs both rose sharply By Stone Shek

AMZN

Analyst Ratings

7 Analysts Have This to Say About Axalta Coating Sys

By Benzinga Insights

July 11, 10:19 AM

Over the past 3 months, 7 analysts have published their opinion on Axalta Coating Sys (NYSE:AXTA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

AXTA

Reported Late Tuesday April 4, Thorne Healthtech Shares Results Of Collaborative Clinical Trial With Mayo Clinic And Healthtech Connex, Inc.; Significant Findings From A Double-blinded, Placebo-Controlled Trial That Measured Brain Function

By Happy Mohamed

April 5, 12:35 AM

Significant positive findings from a double-blinded, placebo-controlled trial that measured brain function in ice hockey players over a season NEW YORK, April 4, 2023 /PRNewswire/ -- Thorne HealthTech, Inc.

THRN